Therefore, during the progression of pancreatic cancer, TLR3 acts as a double-edged sword, serving as part of the immune system’s defense while potentially accelerating the malignant transformation of tumors due to chronic inflammation. Here, TLR3 is linked to pancreatic neoplasm.